After completing this activity, pharmacists should be able to:
1. appraise latest evidence on the use of low-dose aspirin for primary prevention of cardiovascular disease;
2. evaluate the risk/benefit of low-dose aspirin in primary prevention of cardiovascular disease;
3. counsel patients on the role of low-dose aspirin in primary prevention of cardiovascular disease.
The 2016 Competency Standards addressed by this activity include: 1.5, 2.2, 2.3, 3.1, 3.2, 3.3, 3.5
Accreditation number: CX19014 Accreditation expires: 01/04/2021
This activity has been accredited for 1.0 hour of Group One CPD (or 1.0 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which may be converted to 1.0 hour of Group Two CPD (or 2.0 CPD credits) upon successful completion of the associated assessment activity.